Back to Dashboard
SNY · Healthcare

SANOFI SA

Europe Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
20
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in SANOFI SA? Here's what to do with it.
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$105.0B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About SANOFI SA

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop…

Who's behind the signal
Every informed buyer we can see on SNY, across all three feeds.
Hedge funds · 4
Citadel Advisors Increased +62%
AQR Capital Management Increased +2%
Point72 (Steve Cohen) Decreased −10%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 2
Every disclosed buy & sell on record — STOCK Act filings
Trade date Member Chamber Action Amount
2017-06-15 Patty Murray Senate SOLD $1,001 - $15,000
2017-03-16 Patty Murray Senate BOUGHT $1,001 - $15,000
Not a model pick — but on our radar. SANOFI SA isn't in the top-10 model right now, but 4 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
4
Investors
0
New positions
2
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
Increased +62%
% of portfolio
0.0%
Position change
+62%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Increased +2%
% of portfolio
0.0%
Position change
+2%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.1×
Decreased −10%
% of portfolio
0.0%
Position change
−10%
0.0% of Point72's portfolio
Trust weight: 1.0×
Decreased −90%
% of portfolio
0.0%
Position change
−90%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to SANOFI SA
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell SANOFI SA or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime